Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD

Company: Insilico Medicine, Inc

Job title: Founder and CEO


Dr. Zhavoronkov is the founder and CEO of Insilico Medicine, a Baltimore-based leader in the next-generation artificial intelligence and blockchain technologies for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI. Since 2012 he published over 100 peer-reviewed research papers and two books. He organizes the annual Artificial Intelligence and Blockchain for Healthcare Forum at EMBO/Basel Life in Basel. Dr. Zhavoronkov is an adjunct professor at the Buck Institute for Research on Aging.


AI-Powered End-to-End Pipelines for Drug Discovery 3:40 pm

Detailing on how artificial techniques such as deep learning, reinforcement learning (RL), and generative adversarial networks (GANs) present opportunities for studying the biology of aging on the many levels and generating hypotheses for interventions Developing multi-modal predictors of age using a variety of data types ranging from imaging and common blood tests to transcriptomic and…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.